Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens.
Klemis V, Schmidt T, Schub D, Mihm J, Marx S, Abu-Omar A, Ziegler L, Hielscher F, Guckelmus C, Urschel R, Wagenpfeil S, Schneitler S, Becker SL, Gärtner BC, Sester U, Sester M.
Klemis V, et al. Among authors: sester m, sester u.
Nat Commun. 2022 Aug 11;13(1):4710. doi: 10.1038/s41467-022-32321-0.
Nat Commun. 2022.
PMID: 35953492
Free PMC article.